Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Narachi currently holds 14,058 shares of Ultragenyx Pharmaceutical Inc. (RARE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Narachi has been a net seller of RARE stock. They have purchased $766.1K and sold $3.5M worth of shares.
Michael Narachi's most recent insider trade was on May 14, 2026, when they sold 14,058 shares at $0.00 per share.
Michael Narachi serves as Executive at Ultragenyx Pharmaceutical Inc. (RARE). They have executed 35 insider transactions totaling $4.2M over their tenure at the company.
Michael Narachi holds the position of Executive at Ultragenyx Pharmaceutical Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Michael Narachi has shown a selling trading pattern, with $766.1K in total purchases and $3.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael Narachi was on Jul 13, 2012, when they sold $985.6K worth of OREX shares. This transaction involved 147,100 shares at $6.70 per share.
Michael Narachi currently owns 14,058 shares of Ultragenyx Pharmaceutical Inc. (RARE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Narachi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Narachi has 35 Form 4 filings on record as an insider at Ultragenyx Pharmaceutical Inc..
Set alerts for Michael Narachi and 40,000+ other insiders.